Transformational performance in 2020Continued strong demand for COVID-19 testing in 2021Strategy to deliver long-term growth through test, instrument, and geographic expansion in key areas, supplemented by M&A https://novacyt.com/wp-content/uploads/2021/06/Novacyt-full-year-2020-results-Final-ENGLISH.pdf ...

Paris, France et Camberley, Royaume-Uni – 26 mai 2021 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste international du diagnostic clinique, annonce l'expansion de son portefeuille de...

Paris, France and Camberley, UK – 26 May 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces the expansion of its VersaLab™ portfolio with...

Paris, France and Camberley, UK – 21 May 2021 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an update to its ongoing dispute with...